A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is a multisite, randomized, double-blind, placebo-controlled, phase 2/3 study of MG01CI (1400 mg daily) for 6 weeks compared with placebo in a 1:1 ratio of 300 adults with ADHD.
Epistemonikos ID: 247ee636f95c30b39d0d41a9e3878db3904053be
First added on: May 11, 2024